Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 11791 - 11797 of 11797 results

First page
Previous page
1180
Next page disabled
Next page disabled

DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S)

83D19O7250

Status:

Possibly Marketed Outside US

Source:

ANDA204608

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27d39f64-ee15-4beb-bbd0-31f8c42ca5e0

First approved in 1975

Source:

ANDA211396

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4259bb8-91f8-4587-8ceb-35d44145aec0

Class:

CONCEPT

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S)

9N5G1G3D3H

Status:

Possibly Marketed Outside US

Source:

ANDA076258

(1968)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a2238e9-4b5d-c56d-8663-dd354ff9ae0c

First approved in 1968

Source:

ANDA076258

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a2238e9-4b5d-c56d-8663-dd354ff9ae0c

Class:

CONCEPT

HEMOGLOBIN GLUTAMER-250 (BOVINE)

1XQE66T19H

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:B05AA10

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/1XQE66T19H

Class:

CONCEPT

MUROMONAB-CD3

JGA39ICE2V

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:L04AA02

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/JGA39ICE2V

Class:

CONCEPT

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN

7XB76X2V7T

Status:

Possibly Marketed Outside US

Source:

NCT03180034: Phase 4 Interventional Active, not recruiting Human Papillomavirus Infection

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03180034

Class:

CONCEPT

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN

M7H9CF9G0Z

Status:

Possibly Marketed Outside US

Source:

NCT03180034: Phase 4 Interventional Active, not recruiting Human Papillomavirus Infection

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03180034

Class:

CONCEPT

DYSPROSIUM DY-165

VR6LK1GNZ0

Status:

Possibly Marketed Outside US

Source:

WHO-ATC:V10AX03

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VR6LK1GNZ0

Class:

CONCEPT

Concept

DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S)

Concept

TRIMETHYLSILYL TREATED DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 5000000 PA.S)

Concept

HEMOGLOBIN GLUTAMER-250 (BOVINE)

Concept

Concept

HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN

Concept

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN

Concept

DYSPROSIUM DY-165

Showing 11791 - 11797 of 11797 results

First page
Previous page
1180
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1